Astec LifeSciences has allotted 2000 equity shares under ESOP. With the aforesaid allotment, the total Paid-up equity share capital of the Company stands at Rs.19,57,03,550/- comprising of 1,95,70,355 equity shares of Rs 10 each.

Powered by Capital Market - Live News

Consolidated profit before tax (PBT) surged 96% to Rs 39.63 crore in Q4 March 2020 over Q4 March 2019. The board of the company recommended a final dividend of Rs 1.5 per equity share.

The stock has surged 24.35% in last one week from its previous closing of Rs 417.35 posted on 29 April 2020. The benchmark BSE Sensex has fallen 2.9% in the same period.

Astec LifeSciences manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company has manufacturing facilities located at two locations in Maharashtra, India comprising of three units viz. one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra.

Powered by Capital Market - Live News

Astec Lifesciences announced that the Annual General Meeting (AGM) of the company will be held on 22 July 2020.

Powered by Capital Market - Live News

Astec Lifesciences announced that the Board of Directors of the Company at its meeting held on 05 May 2020, has recommended a Final dividend of Rs.1.50 per share (i.e.15%), subject to the approval of the shareholders.

Powered by Capital Market - Live News